Owner Vertex Pharmaceuticals Incorporated

Inventors Salituro, Francesco G.; Ledeboer, Mark W.; Ledford, Brian; Wang, Jian; Pierce, Albert C.; Duffy, John P.; Messersmith, David

Agent Cullens

Pub. Number AU-A-2012205127

Parent 2005286968

Filing date 13 July 2012

Wipo publication date 2 August 2012

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 31/4439

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 37/08 Drugs for immunological or allergic disorders

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups